Skye Bioscience, Inc. [EMBI]

Source: 

Company Overview

Skye Bioscience, Inc is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of a novel class of cannabinoid derivatives to modulate the endocannabinoid system, which has been shown to play a vital role in overall human health and, notably, in multiple ocular indications.